Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Exchange Rate Effect (2016 - 2025)

Traws Pharma (TRAW) has disclosed Exchange Rate Effect for 13 consecutive years, with -$3000.0 as the latest value for Q3 2025.

  • For Q3 2025, Exchange Rate Effect changed N/A year-over-year to -$3000.0; the TTM value through Dec 2025 reached $48000.0, up 352.63%, while the annual FY2025 figure was $48000.0, 352.63% up from the prior year.
  • Exchange Rate Effect hit -$3000.0 in Q3 2025 for Traws Pharma, down from $28000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $28000.0 in Q4 2022 and bottomed at -$20000.0 in Q2 2022.
  • Average Exchange Rate Effect over 5 years is -$444.44, with a median of -$3000.0 recorded in 2024.
  • Year-over-year, Exchange Rate Effect crashed 600.0% in 2022 and then soared 1033.33% in 2025.
  • Traws Pharma's Exchange Rate Effect stood at -$8000.0 in 2021, then surged by 450.0% to $28000.0 in 2022, then crashed by 75.0% to $7000.0 in 2023, then crashed by 228.57% to -$9000.0 in 2024, then surged by 66.67% to -$3000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$3000.0, $28000.0, and $23000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.